????????? ????? ??????? ???????? ???????????????????? ????????? ????Duvelisib was the 2nd PI3K inhibitor accepted with the FDA, also dependant on a stage III randomized trial.130 The efficacy and safety profile in the drug appear equivalent with People of idelalisib, Otherwise marginally beneficial. Pertaining to option BTK inhibitors, there are nu